An Exploratory Study to Assess the Effects of JNJ-39439335 on the Relief of Pain Using a Thermal-Grill Experimental Model

Phase 1 Completed 12 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

RandomizedCrossoverTriple-blindBasic science

Summary

This exploratory study will use a thermal-grill experimental model to assess the effects of JNJ-39439335 (50 mg, single oral dose) on the relief of pain.

Timeline

Start: 2009-06
Primary completion: —
Completion: 2010-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	MAVATREP	Small molecule	50 mg	Oral

Indications

No indication recorded.